STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNS
  4. [Form 4] Cohen & Steers Inc. Insider Trading Activity

CNS Form 4: CEO Joseph Harvey Receives 1,170 RSUs; Significant Insider Holdings Remain

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Joseph M. Harvey, Chief Executive Officer and director of Cohen & Steers, Inc. (CNS), reported a Form 4 filing documenting an internal accrual of dividend-equivalent restricted stock units. The filing shows 1,170 shares were acquired on 08/21/2025 as dividend-equivalent restricted stock units that vested (or were credited) at a price of $0. The report also discloses beneficial holdings including 1,287,031 shares reported following the transaction and 305,000 shares held indirectly through an LLC owned by a family trust, of which Mr. Harvey disclaims beneficial ownership except to the extent of his pecuniary interest. The form was signed by an attorney-in-fact on 08/22/2025.

Positive

  • Acquisition of 1,170 dividend-equivalent RSUs credited to existing unvested restricted stock units, reflecting continued compensation alignment with shareholders
  • Substantial reported beneficial ownership following the transaction (1,287,031 shares) indicating significant insider stake
  • 305,000 shares held indirectly via an LLC associated with a family trust, showing additional retained economic interest

Negative

  • None.

Insights

TL;DR: Routine insider crediting of dividend-equivalent RSUs; significant aggregate holdings remain largely unchanged.

The Form 4 documents a non-cash accrual of 1,170 dividend-equivalent restricted stock units to the CEO, consistent with compensation practices tied to outstanding restricted stock grants from 2022-2025. The filing also clarifies an indirect block of 305,000 shares held through an LLC associated with a family trust, with a disclaimer of beneficial ownership except for pecuniary interest. This is a standard disclosure reflecting compensation mechanics and retained insider stake; it does not indicate a deliberate buy or sell decision by the reporting person.

TL;DR: Small non-cash issuance, large insider stake persists; minimal immediate market impact.

The reported acquisition of 1,170 shares at $0 are dividend-equivalent RSUs credited to unvested grants and therefore represent compensation accounting rather than market purchases. The aggregate post-transaction beneficial ownership of 1,287,031 shares (plus 305,000 indirectly held via an LLC) indicates substantial insider alignment with shareholders. Because the transaction is non-cash and modest in size relative to total holdings, it is unlikely to affect trading volumes or valuation in the near term.

Insider Harvey Joseph M
Role Chief Executive Officer
Type Security Shares Price Value
Grant/Award Common Stock 1,170 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 1,287,031 shares (Direct); Common Stock — 305,000 shares (Indirect, By LLC)
Footnotes (1)
  1. Shares held in a limited liability company owned by a family trust. Mr. Harvey disclaims beneficial ownership of these shares except to the extent of his pecuniary interest. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2025 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2022, January 2023, January 2024 and January 2025.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Harvey Joseph M
(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS
(Street)
NEW YORK NY 10036
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 305,000 I By LLC(1)
Common Stock 08/21/2025 A 1,170(2) A $0 1,287,031 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares held in a limited liability company owned by a family trust. Mr. Harvey disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
2. Represents the acquisition of dividend equivalent restricted stock units in connection with the issuer's third quarter 2025 dividend and accrued to the reporting person on unvested restricted stock units granted in January 2022, January 2023, January 2024 and January 2025.
Remarks:
/s/ Brian W. Heller, Attorney-in-Fact 08/22/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did Joseph M. Harvey report on Form 4 for CNS?

He reported the acquisition of 1,170 dividend-equivalent restricted stock units credited on 08/21/2025 and disclosed existing beneficial holdings.

How many shares does the filing show after the transaction?

The filing shows 1,287,031 shares beneficially owned following the reported transaction.

What is the nature of the 305,000 shares listed in the Form 4?

The 305,000 shares are held indirectly by an LLC owned by a family trust; Mr. Harvey disclaims beneficial ownership except to the extent of his pecuniary interest.

Was cash paid for the 1,170 shares reported?

No; the transaction price is listed as $0, reflecting dividend-equivalent restricted stock units credited to unvested RSUs.

When was the Form 4 signed and filed?

The signature by attorney-in-fact is dated 08/22/2025 and the transaction date is 08/21/2025.